Siemens Healthineers AG Overview
Pro stress-test →Siemens Healthineers is a global provider of healthcare products, solutions and services including clinical consulting services and training. The company operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. In fiscal year 2025, revenue reached €23.38 billion, an increase of 4.53% compared to the prior year.
Strategic Profile
Pro stress-test →The company emphasizes its 'Elevating Health Globally' strategy, focusing on patient twinning, healthcare AI, and precision therapy to address major health challenges including neurodegenerative diseases, cardiovascular conditions, stroke, and cancer. Siemens AG announced its decision to deconsolidate its remaining approximately 67% stake in Siemens Healthineers, handing a 30% stake to its own shareholders to reduce exposure to medical technology and focus on software. Revenue growth of about 5.7% per year is described as slightly below the wider German market forecast, with the bullish view leaning more on efficiency and margin support than on outperformance in sales growth.
Competitive Landscape
Pro stress-test →Current P/E of 21.8x sits below both peer average of 30x and industry average of 24.9x. Major competitors include Philips (imaging and diagnostics), GE Healthcare (medical imaging), and Drägerwerk (medical devices). The company's broad portfolio across imaging, diagnostics, oncology, and minimally invasive therapy positions it competitively against fragmented competitors.
Industry Context
Siemens Healthineers AG operates in Medical Technology / Diagnostic Imaging & Therapeutic Equipment.
Key facts
Founded: 1896 · Headquarters: Forchheim, Germany · Employees: 73,840 · Revenue: €23.4B